RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Lawrence D. Stern, Chairman and Chief Executive Officer of Talecris, will present at the Goldman Sachs Leveraged Finance Healthcare Conference at 8:15 a.m., Wednesday, Mar. 17 at the Goldman Sachs Conference Center in New York.
